| COS Unique Id: |
108035 |
| Title: |
Investigator Initiated Multi-Site Clinical Trials (R01) |
| Sponsor: |
Department of Health and Human Services (HHS)
National Institutes of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
|
| Sponsor Type: |
Federal, U.S. |
| Deadline: |
June 5, 2008
October 5, 2008
February 5, 2009
|
| Deadline Note: |
This program will expire on May 8, 2010.
Applicants
requesting direct costs of $500,000 or more in any one year (excluding
consortium F&A costs) must consult with institute program and
review staff well in advance of (i.e., at least three months prior to)
the anticipated submission date. |
| Amount Note: |
This program will use the R01 grant mechanism.
Because the nature and scope of the proposed research will vary from
application to application, it is anticipated that the size and
duration of each award will also vary. Awards may be converted by NHLBI
to cooperative agreements (U01). |
| Eligibility: |
Applications may be submitted by domestic or
foreign, for-profit or nonprofit organizations and public or private
institutions, such as universities, colleges, hospitals, and
laboratories; units of state and local governments; eligible agencies
of the federal government; and faith-based or community-based
organizations. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Government
Nonprofit
Academic Institution
|
| Abstract: |
The purpose of this funding opportunity
announcement is to provide a vehicle for submitting grant applications
for investigator initiated multi-site (Phase II or Phase III)
randomized, controlled clinical trials. The trials may address any
research question related to the mission and goals of the National
Heart, Lung, and Blood Institute (NHLBI) and may involve clinical or
behavioral interventions. The trials may randomize at the individual
(patient) level or at a group or "cluster" level (e.g., randomization
of clinics, schools, worksites, etc.).
The proposed research
must address a scientifically important question, must provide valuable
information to the existing knowledge base, and must have public health
applicability. Research topics should be based on the NHLBI's national
program plan areas of heart, lung, and blood diseases, and sleep
disorders. |
| Contact Name: |
Craig Bagdon |
| Contact Address: |
Office of Grants Management
Division of Extramural Research Activities
National Heart, Lung, and Blood Institute
6701 Rockledge Drive, MCS7926 |
| Contact City: |
Bethesda |
| Contact State: |
Maryland |
| Contact Zip: |
20892-7926 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (301) 435-0166 |
| Contact Fax: |
+1 (301) 480-3310 |
| Contact Email: |
BagdonC@mail.nih.gov |
| URL for more information: |
http://grants1.nih.gov/grants/guide/pa-files/PAR-07-373.html |
| Date Last Revised: |
March 10, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=108035 |
| Keywords: |
Blood Diseases
Clinical Trial
Heart Diseases
Sleep Disorders
|
| Sponsor Reference No: |
PAR-07-373 |
| Funding Type: |
Research
|
| COS Unique Id: |
111314 |
| Title: |
Special Emphasis Notice (SEN): AHRQ Announces
Interest in Research on Diagnostic Errors in Ambulatory Care Settings
(Unsolicited Proposals) |
| Sponsor: |
Department of Health and Human Services (HHS)
Agency for Healthcare Research and Quality (AHRQ)
|
| Sponsor Type: |
Federal, U.S. |
| Deadline Note: |
Continuous. AHRQ announced in the October 26, 2007,
edition of the NIH Guide to Programs that "AHRQ is providing
information about one of the highest research priorities for
unsolicited applications for fiscal year 2008. AHRQ will continue to
provide regular updates of research priorities as research budget
information becomes available. Applications focused on areas identified
in this SEN should be submitted on regular research grant receipt dates
and will be reviewed by AHRQ's standing study sections."
Information
about the grant application process, including e-grant applications and
the funding mechanisms noted above, can be found at http://www.ahrq.gov/fund/. |
| Amount Note: |
AHRQ will use standing grant mechanisms such as the
R01, R03, R18, K08, and K02 funding mechanisms to support research on
diagnostic errors. Applications will be funded for one to three years.
Due to limitations on available grant funds, AHRQ limits the total
(direct plus indirect) costs for the R01 and R18 mechanisms to no more
than $300,000 per year. R03 applications are limited to total (direct
plus indirect) costs of no more than $100,000 per year. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Small Business
Ph.D./M.D./Other Professional
Commercial
Government
Nonprofit
Academic Institution
|
| Abstract: |
In FY 2008, the Agency for Healthcare Research and
Quality (AHRQ) intends to support research designed to gain a better
understanding of the incidence, cost, determinants, and strategies for
preventing or mitigating diagnostic errors (i.e., misdiagnosis, missed
diagnosis, delayed diagnosis) in ambulatory care settings. For the
purposes of this Special Emphasis Notice (SEN), ambulatory care refers
to health care provided in emergency departments; clinicians' offices
and practices, both large and small; outpatient clinics; community
health centers; urgent care centers; and ambulatory surgery centers.
Researchers
from non-ambulatory settings with a strong interest in fostering safe,
high quality ambulatory care and transitions are welcome to apply, but
must do so in partnership with an ambulatory care organization. In
particular, a focus on transitions between ambulatory care, home care,
and nursing homes is critical to the success of ambulatory care for
many elderly and chronically ill populations.
For purposes of
this SEN, priority populations include low-income patients and the
uninsured along with AHRQ's other priority populations (children,
women, elderly, racial and ethnic minorities, and individuals with
special health care needs).
Additional Contact:
Kay Anderson, Ph.D. (K02 and K08 inquiries)
Office of Extramural Research, Education, and Priority Populations
+1 (301) 427-1555
kay.anderson@ahrq.hhs.gov. |
| Contact Name: |
Kerm Henriksen, Ph.D. (R01, R03, and R18 inquiries) |
| Contact Address: |
Center for Quality Improvement and Patient Safety |
| Contact City: |
Rockville |
| Contact State: |
Maryland |
| Contact Zip: |
20852 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (301) 427-1331 |
| Contact Email: |
kerm.henriksen@ahrq.hhs.gov |
| URL for more information: |
http://grants1.nih.gov/grants/guide/notice-files/NOT-HS-08-002.html |
| Date Last Revised: |
March 10, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=111314 |
| Keywords: |
Health Care
Health Services Delivery
Medical Diagnosis
|
| Sponsor Reference No: |
NOT-HS-08-002 |
| Funding Type: |
Research
|
| COS Unique Id: |
112925 |
| Title: |
Clinical Research Awards |
| Sponsor: |
United States Department of Defense (DOD)
Department of the Army
U.S. Army Medical Research and Materiel Command (USAMRMC)
Congressionally Directed Medical Research Programs (CDMP)
Tuberous Sclerosis Complex Research Program (TSCRP)
|
| Sponsor Type: |
Federal, U.S. |
| Deadline: |
May 22, 2008
|
| Deadline Note: |
Pre-applications are due by May 22, 2008. The deadline for submission of proposals is June 12, 2008. |
| Upper Amount: |
$300,000 |
| Amount Note: |
Funding for a Clinical Research Award can be
requested for up to $300,000 for direct costs for up to a three-year
performance period, plus indirect costs as appropriate. |
| Eligibility: |
Investigators at or above the Assistant Professor level (or equivalent) are eligible to submit proposals. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Ph.D./M.D./Other Professional
|
| Abstract: |
The Tuberous Sclerosis Complex Research Program
(TSCRP) Clinical Research Award supports TSC research projects
performed by clinical researchers involved in the support of clinical
care of individuals with TSC. Proposed research should have a direct
link to TSC clinical outcomes.
Important aspects of the Clinical Research Award are as follows:
1. The PI must have guaranteed protected time of 10 percent or higher as indicated in the letter of institutional support.
2.
The research should lead to a demonstrated improvement in clinical
outcomes or the development of a metric for clinical outcomes.
3. All proposals must include preliminary data relevant to TSC research and the proposed project. |
| Contact Country: |
United States |
| Contact Phone: |
+1 (301) 619-7079 |
| Contact Fax: |
+1 (301) 619-7792 |
| Contact Email: |
cdmrp.pa@amedd.army.mil |
| URL for more information: |
http://cdmrp.army.mil/funding/tscrp.htm |
| Date Last Revised: |
March 14, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=112925 |
| Keywords: |
Genetic Diseases
Tumor Immunology
Tumors
|
| Sponsor Reference No: |
W81XWH-08-TSCRP-CRA |
| Funding Type: |
Research
|
| COS Unique Id: |
112926 |
| Title: |
Career Transition Award |
| Sponsor: |
United States Department of Defense (DOD)
Department of the Army
U.S. Army Medical Research and Materiel Command (USAMRMC)
Congressionally Directed Medical Research Programs (CDMP)
Tuberous Sclerosis Complex Research Program (TSCRP)
|
| Sponsor Type: |
Federal, U.S. |
| Deadline: |
May 22, 2008
|
| Deadline Note: |
Pre-applications are due by May 22, 2008. The deadline for submission of proposals is June 12, 2008. |
| Upper Amount: |
$338,000 |
| Amount Note: |
Funding for a Career Transition Award can be
requested for up to $338,000 for direct costs for up to a four-year
performance period, plus indirect costs as appropriate. This includes
up to $69,000 per year, for up to two years, for each postdoctoral year
in direct costs and up to $100,000 per year, for up to two years, for
faculty-level position years in direct costs, plus indirect costs as
appropriate. |
| Eligibility: |
Postdoctoral investigators within two to three years of completing their postdoctoral work are eligible to submit proposals. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Ph.D./M.D./Other Professional
|
| Abstract: |
The Tuberous Sclerosis Complex Research Program
(TSCRP) Career Transition Award supports TSC researchers during the
transition from postdoctoral training to an independent position. This
award will cover up to two years of postdoctoral training followed by
up to two years of a faculty-level position. For the purposes of this
award, the postdoctoral candidate is considered the Principal
Investigator (PI).
Important aspects of the Career Transition Award are as follows:
1. The award covers the last two years of a postdoctoral fellowship and the first two years of an independent faculty position.
2. All proposals must include preliminary data relevant to TSC research and the proposed project.
3. Career transition and development plans must be clearly articulated.
4. A named mentor who will support and guide the PI during the postdoctoral period of the award. |
| Contact Country: |
United States |
| Contact Phone: |
+1 (301) 619-7079 |
| Contact Fax: |
+1 (301) 619-7792 |
| Contact Email: |
cdmrp.pa@amedd.army.mil |
| URL for more information: |
http://cdmrp.army.mil/funding/tscrp.htm |
| Date Last Revised: |
March 14, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=112926 |
| Keywords: |
Genetic Diseases
Tumor Immunology
Tumors
|
| Sponsor Reference No: |
W81XWH-08-TSCRP-CARTA |
| Funding Type: |
Research
|
| COS Unique Id: |
113042 |
| Title: |
Grand Challenges Explorations |
| Sponsor: |
Grand Challenges in Global Health Initiative
|
| Sponsor Type: |
Other Nonprofit |
| Deadline: |
May 15, 2008
|
| Deadline Note: |
The application process runs March 31-May 30, 2008,
and requires online pre-registration by May 15, 2008. All applications
will be submitted through an online system. |
| Amount Note: |
Initial grants will be awarded multiple times per
year at approximately $100,000 each. An additional $1 million in
funding will be available for projects that show promise. The first
grants are expected to be announced by fall 2008. |
| Eligibility: |
The initiative accepts applications from individuals at both private and public organizations. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Ph.D./M.D./Other Professional
|
| Abstract: |
Grand Challenges Explorations will foster
early-stage innovation in global health research and expand the
pipeline of ideas that merit further exploration. The program will
employ a new, fast-track approach to grant making, with short two-page
applications and no preliminary data required. Each round of the Grand
Challenges Explorations initiative will award grants against a set of
specific topics. For Round 1, the topics are as follows:
- Explore the Basis of Latency in Tuberculosis
- Create New Ways to Prevent or Cure HIV Infection
- Create New Ways of Protecting Against Infectious Disease
- Create New Drugs and Delivery Systems to Limit the Emergence of Resistance
In general, topics are chosen according to three major criteria:
1. The topic fits within the goals and disease priorities of the Grand Challenges in Global Health.
2. The topic contains a roadblock where radical, new thinking is needed for the discovery of an effective health solution.
3. Potential projects within the topic are likely to be well suited for the phased structure of the initiative.
In
addition, the initiative considers whether a topic will engage the
participation from scientists outside traditional global health
disciplines, as well as researchers working in the developing world.
The
Grand Challenges in Global Health initiative is a partnership dedicated
to supporting scientific and technical research to solve critical
health problems in the developing world. The initiative's partners are
the Bill & Melinda Gates Foundation, the Canadian Institutes of
Health Research, the Foundation for the National Institutes of Health,
and the Wellcome Trust. |
| Contact Country: |
United States |
| Contact Email: |
GCGHWebmaster@gatesfoundation.org |
| URL for more information: |
http://www.gcgh.org/explorations |
| Date Last Revised: |
March 14, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=113042 |
| Keywords: |
Antimicrobial Resistance
HIV
HIV Prevention
Infectious Diseases or Agents
International Health
Tuberculosis
|
| Funding Type: |
Research
|
| COS Unique Id: |
20238 |
| Title: |
Prader-Willi Syndrome Research Funding Opportunities |
| Sponsor: |
Prader-Willi Syndrome Association (USA)
|
| Sponsor Type: |
Other Nonprofit |
| Deadline: |
May 20, 2008
|
| Deadline Note: |
A letter of intent is due May 20, 2008. Invitations
for full grant applications will be issued by June 25, 2008, and
applications will be due September 10, 2008. |
| Upper Amount: |
$100,000 |
| Amount Note: |
The maximum single grant allowed will be $50,000
per-year, for a maximum length of two years (the second year funding
contingent on the timely receipt of the first year's progress report
and status). |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Ph.D./M.D./Other Professional
|
| Abstract: |
The Prader-Willi Syndrome Association USA [PWSA
(USA)] is pleased to offer grant assistance for scientific researchers
with an interest in improving the lives of those with Prader-Willi
syndrome (PWS). PWSA (USA) is especially interested in supporting
research projects that have the potential for immediate and high impact
to the PWS community. However, PWSA also seeks to balance its research
funding between basic and applied research in order to seek new
insights that could benefit its membership right away as well as to
elucidate the causes of Prader-Willi syndrome in order to spur more
potent and complete therapies in the future.
While PWSA (USA) is
open to insightful grants in any subject area, the following areas are
of particular interest to its constituency at this time. Research
(basic or applied) in these areas will receive the highest priority:
1.
Obesity - Obesity is the number one threat to the life expectancy and
quality of life of someone with PWS. The resulting medical consequences
of obesity and controlling obesity combined with the extraordinary
stress that these issues bring to families makes hyperphagia a central
life-long threat to those living with PWS.
2. Respiratory - Due to
lifelong hypotonia and the complications of obesity, individuals with
PWS are at risk for pulmonary issues. Sleep apnea, health risks due to
upper respiratory infections, and aspiration are some of the concerns
that PWSA (USA) believes are worth studying.
3. Other topics - Behavior and psychology, gastrointestinal (GI)
issues, appetite suppressors, genomics and proteomics, brain imaging and function, biomarkers for co-morbidities
Additional Contact:
Merlin G. Butler, M.D., Ph.D.
Children's Mercy Hospital
Section of Medical Genetics and Molecular Medicine
2401 Gillham Road - GGC520
Kansas City, Missouri 64108
+1 (816) 234-3290
MGButler@CMH.edu |
| Contact Name: |
Janalee Heinemann, Director of Research and Medical Affairs |
| Contact Address: |
Prader-Willi Syndrome Association (USA)
8588 Potter Park Drive, Suite 500 |
| Contact City: |
Sarasota |
| Contact State: |
Florida |
| Contact Zip: |
34238 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (941) 487-6729 |
| Contact Fax: |
+1 (941) 312-0142 |
| Contact Email: |
jheinemann@pwsausa.org |
| URL for more information: |
http://www.pwsausa.org/research/letter_of_intent.htm |
| Date Last Revised: |
March 10, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=20238 |
| Keywords: |
Cardiopulmonary Chest Medicine
Digestive Diseases and Disorders
Endocrine System
Endocrinologic Diseases
Endocrinology
Gastroenterology
Genetic Diseases
Genetics
Neurological Disorders
Neurology
Obesity
Respiratory Diseases
Respiratory System
Respiratory Therapy
Sleep Disorders
|
| Funding Type: |
Research
|
| COS Unique Id: |
24990 |
| Title: |
Jeffrey P. LaFage Graduate Student Research Award |
| Sponsor: |
Entomological Society of America (ESA)
|
| Sponsor Type: |
Professional Society or Association |
| Deadline: |
July 1, 2008
|
| Amount Note: |
The award amount is unspecified. The amount of this award is based on the earnings from the endowment. |
| Eligibility: |
The applicant must be a candidate for a master's or doctoral degree at an accredited university.
The grant is open to students throughout the world. |
| Citizenship or Residency: |
Unrestricted
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Graduate Student
|
| Abstract: |
The Jeffrey P. LaFage Graduate Student Research
Award was established by an endowment from donations by Rousell Bio,
Dow AgroSciences, FMC, and the friends and family of Dr. Jeffery P.
LaFage. It is awarded to a graduate student who proposes innovative
research that advances or contributes significantly to the knowledge of
the biology or control of pests in the urban environment, especially
termites or other wood-destroying organisms. This grant may be used for
salaries, equipment, supplies, or travel to initiate, accelerate,
augment, or expand a research project.
Priority will be given to proposals demonstrating a creative and realistic approach to the fields of interest. |
| Contact Address: |
Entomological Society of America
10001 Derekwood Lane, Suite 100 |
| Contact City: |
Lanham |
| Contact State: |
Maryland |
| Contact Zip: |
20706-3115 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (301) 731-4535 |
| Contact Fax: |
+1 (301) 731-4538 |
| Contact Email: |
melodie@entfdn.org |
| URL for more information: |
http://www.entsoc.org/awards/student/lafage.htm |
| Date Last Revised: |
March 13, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=24990 |
| Keywords: |
Entomology
Pest Management
|
| Funding Type: |
Equipment or Materials Acquisition or Facility Use
Research
Travel
|
| COS Unique Id: |
9455 |
| Title: |
Postdoctoral Fellowships |
| Sponsor: |
American Cancer Society (ACS)
Extramural Grants Program
Mentored Training and Career Development Grants
|
| Sponsor Type: |
Professional Society or Association |
| Deadline: |
April 1, 2008
October 15, 2008
|
| Deadline Note: |
The annual application deadlines are April 1 and
October 15. The electronic applications must be submitted and the paper
copies received at the ACS' National Home Office by close of business
(5:00 P.M. EST) on the specified deadline date. If the deadline falls
on a weekend or holiday, applications will be accepted the following
business day. |
| Amount: |
$40,000 |
| Upper Amount: |
$166,000 |
| Amount Note: |
Awards are made for one to three years with
progressive stipends of $40,000, $42,000, and $44,000 per year, plus a
$4,000 per year institutional allowance. Depending on availability of
special endowment funds, the ACS annually selects one or more of the
top-ranked fellowships to be supplemented above the standard stipend. |
| Eligibility: |
Applicants must at the time of application be
United States citizens, noncitizen nationals, or permanent residents of
the United States.
Funding is made to not-for-profit
institutions located within the United States, its territories, and the
Commonwealth of Puerto Rico.
Unsolicited grant applications
will not be accepted from, nor will grants be made for, the support of
research conducted at for-profit institutions, federal government
agencies (including the National Laboratories), or organizations
supported entirely by the federal government (with the exception of
postdoctoral fellowship applications) or organizations, such as
Foundations operated by, and for the benefit of, Veteran Affairs
Medical Centers, whose primary beneficiaries are federal government
entities. Applications may be submitted by qualified academic
institutions on behalf of Veteran Affairs Medical Centers, provided
that a Dean's Committee Memorandum of Affiliation is in effect between
the two institutions.
Principal investigators who are U.S.
citizens or permanent residents working at a not-for-profit institution
in the United States may request under special circumstances, that a
component of the research be performed at a foreign institution as a
subcontract. In these cases, the principal investigator must convince
the ACS and its review committees that the proposed research cannot be
undertaken at an institution in the United States, and that the
findings will be relevant to the U.S. population. |
| Citizenship or Residency: |
United States
|
| Activity Location: |
Unrestricted
|
| Requirements: |
Ph.D./M.D./Other Professional
|
| Abstract: |
The American Cancer Society (ACS) offers this award
to support the training of researchers who have just received their
doctorate to enable them to qualify for an independent career in cancer
research (including basic, preclinical, clinical, psychosocial,
behavioral, and epidemiologic research). |
| Contact Address: |
American Cancer Society
Extramural Grants Department
250 Williams Street |
| Contact City: |
Atlanta |
| Contact State: |
Georgia |
| Contact Zip: |
30303-1002 |
| Contact Country: |
United States |
| Contact Phone: |
+1 (404) 329-7558 |
| Contact Fax: |
+1 (404) 321-4669 |
| Contact Email: |
grants@cancer.org |
| URL for more information: |
http://www.cancer.org/docroot/RES/content/RES_5_2x_Postdoctoral_Fellowships.asp?sitearea=RES |
| Date Last Revised: |
March 12, 2008 |
| URL from COS to Bookmark this record: |
http://fundingopps.cos.com/cgi-bin/getRec?id=9455 |
| Keywords: |
Cancer Biology
Cancer or Carcinogenesis
Cancer Prevention
Health Care Planning or Policy
Oncology
|
| Funding Type: |
Postdoctoral Award
|
|
|
©2008, ProQuest LLC All rights reserved
|
|
